MedPath

Patients With Implantable Cardiac Devices Requiring a Nuclear Magnetic Resonance

Conditions
Implantable Cardiac Device. Patients With a NMR Indication
Registration Number
NCT04330898
Lead Sponsor
Trialance SCCL
Brief Summary

The general objective of this registry is to study the number of patients carrying an implantable cardiac device that have an indication for an imaging diagnosis based on nuclear magnetic resonance. Is wanted to know the cause of the indication of the diagnostic test based on MRI.

Detailed Description

MRI is currently infra indicated in patients with cardiac stimulation devices and for this reason, the request for this imaging technique in these patients is complicated and, often, the MRI-based test is replaced by a CT scan that may not be so beneficial for the diagnosis.

Current data indicate that, with cardiological control and maintaining basic safety precautions, MRI could be performed in patients with peacemakers and Implantable Cardioverter Defibrillators (ICD) that require it for clinical reasons, although it should be noted that currently, due to lack of data published, the absolute safety of an MRI in these patients and the protocol used in each case cannot be guaranteed.

This registry proposal is to have data of all patients implanted with Biotronik cardiac stimulation devices and evaluate how many of them have an indication for an MRI-based diagnostic test, how many of them are already undergoing this diagnostic test, how many are given an tomography as an alternative to avoid subjecting patients to an MRI

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
1248
Inclusion Criteria
  • Patients carrying a cardiac stimulation device
  • Patients able to understand the nature of the procedure
  • Patients who give informed consent
Exclusion Criteria
  • Epicardial cables
  • Abandoned cables
  • Non-BIOTRONIK cables
  • Age <18 years
  • Pregnant and breastfeeding
  • Subjects with irreversible brain damage caused by a pre-existing brain disease
  • Heart transplant 6 months prior to recruitment or expected within the next 3 months
  • Cardiac surgery 3 months prior to recruitment or planned for the next 3 months
  • Life expectancy less than 12 months

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percentage of patients with implantable cardiac devices that require a diagnostic test based on MRI1 year

statistical analysis of the variable

Secondary Outcome Measures
NameTimeMethod
Percentage of patients with a non-MRI-based test diagnosis, although they had an indication for an MRI-based diagnostic test because of their disease1 year

statistical analysis of the variable

Cost effectiveness of the he MRI Autodetect function1 year

statistical analysis of the variable

Reasons for not used MRI1 year

statistical analysis of the variable

Analysis of the differences in the workflow1 year

statistical analysis of the variable

Primary indication for MRI1 year

statistical analysis of the variable

Trial Locations

Locations (20)

Hospital San Pedro de Alcantara

🇪🇸

Cáceres, Madrid, Spain

Hospital de Poniente

🇪🇸

El Ejido, Madrid, Spain

Hospital Arquitecto Marcide

🇪🇸

Ferrol, Madrid, Spain

Hospital de Galdakano

🇪🇸

Galdakao, Madrid, Spain

Hospital de Orense

🇪🇸

Orense, Madrid, Spain

Hospital General de Asturias

🇪🇸

Oviedo, Madrid, Spain

Hospital Virgen del Puerto

🇪🇸

Plasencia, Madrid, Spain

Hospital de Puerto Real

🇪🇸

Puerto Real, Madrid, Spain

Hospital Parc Taul'i

🇪🇸

Sabadell, Madrid, Spain

Hospital Marques de Valdecilla

🇪🇸

Santander, Madrid, Spain

Scroll for more (10 remaining)
Hospital San Pedro de Alcantara
🇪🇸Cáceres, Madrid, Spain
Marta Barbacid Hernández, PharmD, MSc
Contact
+34630767668
mbarbacid@trialance.com
Concetta Chirico, PharmTechD
Contact
+34645494281
cchirico@trialance.com
Maria Jose Garcia Ramos, Cardiology
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.